CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-07-24. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 1770 · Search date 2026-07-24 · Methodology v1.0

Therapeutic ultrasound,
does it really help with Reduction of pain and swelling and acceleration of functional recovery after acute ankle sprain?

30-Second Summary
D
Evidence Grade D · 24 · Safety acceptable
It did not improve pain, swelling, or function over sham treatment in acute ankle sprain
What the
research shows
Therapeutic ultrasound is rated D for acute ankle sprain because five sham-controlled trials were repeatedly null but did not exclude a small or moderate benefit. In the six-trial, 606-participant van den Bekerom 2011 review, Cochrane 2011(6):CD001250, one-week improvement across three trials and 341 participants had RR 1.04 (95% CI 0.92 to 1.17) and RD 3% (-6 to 12); function across two trials and 187 participants had RR 1.09 (0.92 to 1.30) and RD 6% (-6 to 19). Upper bounds of 12% and 19% do not exclude benefit, giving D with 24 points. Evidence was not borrowed from verdict 1728, which is D with 28 points, or verdict 1746, which is C with 42 points, because they concern the same device at different body sites.
What the
ads claim
The explanation that sound energy stimulates deep tissue and shortens swelling and recovery is plausible-sounding, but sham-controlled human trials in acute ankle sprain repeatedly found no clinical benefit.
*

Useful facts when choosing a product

  • This is a physical-therapy energy device that delivers high-frequency acoustic energy, not diagnostic ultrasound.
  • Initial assessment should consider fracture, ability to bear weight, severe focal tenderness, and instability.
  • Ultrasound should not replace protection, progressive weight bearing, and exercise rehabilitation.
ID

Chamgap Semantic Classification Code

Candidate index · review held

P.therapeutic-ultrasound.device.pain-and-swelling-and-acceleration-of-functional-recovery-after-acute-ankle-sprain.reduce.sham

Procedures, devices and tests > Therapeutic ultrasound > Device delivered > pain and swelling and acceleration of functional recovery after acute ankle sprain > Reduction claim > Sham procedure or device

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 1770 · D 24
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Nyanzi 1999 (Clin Rehabil 13(1):16-22) was a 58-person double-blind sham-ultrasound randomized trial. Pain, swelling, range of motion, and weight bearing were all null, and no single explicit primary endpoint was clear. It had NHS and academic support with no manufacturer funding reported. Van den Bekerom 2011, Cochrane 2011(6):CD001250, reviewed six trials and 606 participants, including five sham-controlled trials. One-week improvement in three trials and 341 participants had RR 1.04 (95% CI 0.92 to 1.17), RD 3% (-6 to 12); function in two trials and 187 participants had RR 1.09 (0.92 to 1.30), RD 6% (-6 to 19).

02

Why this is classified as D (24)

Five sham-controlled trials were repeatedly null, but one-week improvement RD 3% (-6 to 12) and function RD 6% (-6 to 19) do not exclude a small or moderate benefit. This supports D with 24 points rather than F.

Counterpoint. When recovery is delayed or weight bearing remains difficult, reassessment for fracture or major ligament injury matters more than repeating ultrasound.

Rejudgment record. Cross-check applied — Nyanzi's 58-person double-blind sham-ultrasound trial and five sham-controlled trials were repeatedly null, but one-week improvement RD -6% to 12% and function RD -6% to 19% did not exclude small or moderate benefit, supporting D rather than F

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Pain reduction after acute ankle sprainDResults were repeatedly null, but confidence intervals did not exclude possible benefit.
Swelling reduction after acute ankle sprainDBenefit over sham was unconfirmed and precision was limited.
Recovery of weight bearing and walking functionDFunction had RR 1.09 and RD 6%, with an interval from -6% to 19%.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Nyanzi CS et al. 1999Randomized double-blind sham-controlled trial58 randomized; 58 in the actual analysisAcademic research at Southampton University Hospitals Trust NHS; no manufacturer funding reportedNo single prespecified primary endpoint; pain, swelling, range of motion, and weight-bearing outcome setDay-14 pain was 0.9 versus 0.7, and no outcome significantly favored ultrasound; the outcome set failed.Pivotal direct sham-controlled trial
van den Bekerom MPJ et al. 2011 CochraneSystematic review of randomized and quasi-randomized trialsSix trials and 606 participants; five sham-controlled trialsAcademic Cochrane review; no manufacturer leadership reportedOverall improvement, pain, swelling, functional disability, and range of motionFive sham trials were repeatedly null; one-week improvement in three trials and 341 participants had RR 1.04 (95% CI 0.92 to 1.17), RD 3% (-6 to 12), and function in two trials and 187 participants had RR 1.09 (0.92 to 1.30), RD 6% (-6 to 19).Repeated verification in the same indication
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-24).

Nyanzi CS, Langridge J, Heyworth JRC, Mani R. Randomized controlled study of ultrasound therapy in the management of acute lateral ligament sprains of the ankle joint. Clin Rehabil. 1999;13(1):16-22. PMID: 10327093. DOI: 10.1191/026921599701532081.
checked
van den Bekerom MPJ, van der Windt DAWM, ter Riet G, van der Heijden GJMG, Bouter LM. Therapeutic ultrasound for acute ankle sprains. Cochrane Database Syst Rev. 2011;2011(6):CD001250. PMID: 21678332. DOI: 10.1002/14651858.CD001250.pub2.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-07-24 · Corrections: none

Cite this verdict

Therapeutic ultrasound x acute ankle sprain Evidence Grade D card
[Chamgap] Therapeutic ultrasound x acute ankle sprain — Evidence Grade D·24. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/therapeutic-ultrasound-acute-ankle-sprain-recovery/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.